Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Autoimmune diseases can change hair texture, but treatment can restore it.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Hydroxychloroquine may help delay skin damage in lupus patients.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Five FDA-approved drugs may help block COVID-19 virus entry.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Effective pain management in multiple sclerosis requires individualized treatment strategies.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The guideline provides recommendations for managing alopecia areata effectively.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.